Clearstead Advisors’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.55K Buy
+80
New +$5.28K ﹤0.01% 2160
2026
Q1
Sell
-74
Closed -$6.52K 2623
2025
Q4
$6.52K Buy
74
+14
+23% +$1.19K ﹤0.01% 1970
2025
Q3
$4.99K Sell
60
-102
-63% -$8.88K ﹤0.01% 2158
2025
Q2
$15.1K Buy
162
+60
+59% +$5.68K ﹤0.01% 1740
2025
Q1
$10.8K Sell
102
-17
-14% -$1.75K ﹤0.01% 1592
2024
Q4
$11.5K Buy
119
+27
+29% +$2.69K ﹤0.01% 1539
2024
Q3
$9.09K Hold
92
﹤0.01% 1602
2024
Q2
$7.91K Buy
+92
New +$7.24K ﹤0.01% 1591

Other funds holding MMSI

Clearstead Advisors's MMSI Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Merit Medical Systems (MMSI) in Q2 2026: 80 shares worth $5.55K. The stake represents ﹤0.01% of the portfolio and ranks #2160 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in MMSI as recently as Q4 2025.

Clearstead Advisors first reported a position in MMSI in Q2 2024 and has held it in 8 quarters since. The position peaked at $15.1K in Q2 2025. 403 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • Clearstead Advisors held 80 shares of Merit Medical Systems worth $5.55K as of Q2 2026.
  • Merit Medical Systems was a new Clearstead Advisors position in Q2 2026.
  • Merit Medical Systems made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2160 holding.
  • Clearstead Advisors first reported a position in Merit Medical Systems in Q2 2024 and has held it in 8 quarters since.
  • Clearstead Advisors's Merit Medical Systems position peaked at $15.1K in Q2 2025.
  • 403 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.